nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—Alzheimer's disease—Parkinson's disease	0.764	1	CtDrD
Rivastigmine—CYP2D6—Parkinson's disease	0.203	1	CbGaD
Rivastigmine—Neostigmine—ABCB1—Parkinson's disease	0.000486	0.546	CrCbGaD
Rivastigmine—Tapentadol—CYP2D6—Parkinson's disease	0.000405	0.454	CrCbGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAP3K5—Parkinson's disease	0.000138	0.00434	CbGpPWpGaD
Rivastigmine—CYP3A4—Tamoxifen metabolism—CYP2E1—Parkinson's disease	0.000135	0.00424	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000133	0.00419	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—MAOA—Parkinson's disease	0.000131	0.00412	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—DLG1—Parkinson's disease	0.000131	0.0041	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000127	0.004	CbGpPWpGaD
Rivastigmine—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000126	0.00397	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.000126	0.00395	CbGpPWpGaD
Rivastigmine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000125	0.00392	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000123	0.00387	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—EDN1—Parkinson's disease	0.000122	0.00384	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—INS—Parkinson's disease	0.000117	0.00368	CbGpPWpGaD
Rivastigmine—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000116	0.00363	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPT—Parkinson's disease	0.000115	0.00361	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—GRIK1—Parkinson's disease	0.000115	0.0036	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000113	0.00356	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00011	0.00345	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000106	0.00334	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000106	0.00333	CbGpPWpGaD
Rivastigmine—ACHE—Monoamine Transport—TNF—Parkinson's disease	0.000104	0.00325	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—GRIK1—Parkinson's disease	0.000102	0.00321	CbGpPWpGaD
Rivastigmine—CYP2D6—Melatonin metabolism and effects—APOE—Parkinson's disease	9.94e-05	0.00312	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	9.75e-05	0.00306	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—GRIK2—Parkinson's disease	9.75e-05	0.00306	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—SLC18A2—Parkinson's disease	9.44e-05	0.00296	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	9.18e-05	0.00288	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	8.94e-05	0.00281	CbGpPWpGaD
Rivastigmine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	8.91e-05	0.0028	CbGpPWpGaD
Rivastigmine—CYP2D6—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	8.79e-05	0.00276	CbGpPWpGaD
Rivastigmine—ACHE—Peptide hormone metabolism—INS—Parkinson's disease	8.76e-05	0.00275	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	8.7e-05	0.00273	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—GRIK2—Parkinson's disease	8.69e-05	0.00273	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	8.55e-05	0.00269	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—SLC18A2—Parkinson's disease	8.42e-05	0.00264	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—DLG4—Parkinson's disease	8.39e-05	0.00263	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—HSPA9—Parkinson's disease	8.29e-05	0.0026	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	8.2e-05	0.00257	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	8.08e-05	0.00254	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—MAPK8—Parkinson's disease	8.02e-05	0.00252	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	7.97e-05	0.0025	CbGpPWpGaD
Rivastigmine—BCHE—Peptide hormone metabolism—INS—Parkinson's disease	7.81e-05	0.00245	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	7.63e-05	0.0024	CbGpPWpGaD
Rivastigmine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	7.52e-05	0.00236	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—DLG4—Parkinson's disease	7.48e-05	0.00235	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—CHRNA4—Parkinson's disease	7.47e-05	0.00235	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—HSPA9—Parkinson's disease	7.4e-05	0.00232	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	7.31e-05	0.0023	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	7.22e-05	0.00227	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	7.21e-05	0.00226	CbGpPWpGaD
Rivastigmine—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	7.2e-05	0.00226	CbGpPWpGaD
Rivastigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	7.16e-05	0.00225	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	6.95e-05	0.00218	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABL1—Parkinson's disease	6.93e-05	0.00218	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—COMT—Parkinson's disease	6.87e-05	0.00216	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—HSPA8—Parkinson's disease	6.85e-05	0.00215	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—BDNF—Parkinson's disease	6.83e-05	0.00214	CbGpPWpGaD
Rivastigmine—ACHE—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.82e-05	0.00214	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—Parkinson's disease	6.71e-05	0.00211	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—CHRNA4—Parkinson's disease	6.66e-05	0.00209	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—DLG4—Parkinson's disease	6.43e-05	0.00202	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	6.37e-05	0.002	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTA4—Parkinson's disease	6.33e-05	0.00199	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	6.28e-05	0.00197	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—GRIN2B—Parkinson's disease	6.28e-05	0.00197	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTA4—Parkinson's disease	6.25e-05	0.00196	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—SLC6A3—Parkinson's disease	6.19e-05	0.00194	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—COMT—Parkinson's disease	6.13e-05	0.00192	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—HSPA8—Parkinson's disease	6.11e-05	0.00192	CbGpPWpGaD
Rivastigmine—BCHE—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.08e-05	0.00191	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—FASLG—Parkinson's disease	6.06e-05	0.0019	CbGpPWpGaD
Rivastigmine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	5.94e-05	0.00187	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—RPL6—Parkinson's disease	5.91e-05	0.00186	CbGpPWpGaD
Rivastigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	5.82e-05	0.00183	CbGpPWpGaD
Rivastigmine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	5.75e-05	0.00181	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—DLG4—Parkinson's disease	5.73e-05	0.0018	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	5.64e-05	0.00177	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—GRIN2B—Parkinson's disease	5.6e-05	0.00176	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	5.6e-05	0.00176	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—SLC6A3—Parkinson's disease	5.52e-05	0.00173	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	5.34e-05	0.00168	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—RPL6—Parkinson's disease	5.27e-05	0.00166	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—COMT—Parkinson's disease	5.26e-05	0.00165	CbGpPWpGaD
Rivastigmine—ACHE—Neuronal System—MAOA—Parkinson's disease	5.23e-05	0.00164	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	5.16e-05	0.00162	CbGpPWpGaD
Rivastigmine—ACHE—ATF-2 transcription factor network—IL6—Parkinson's disease	5.12e-05	0.00161	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—DCTN1—Parkinson's disease	5.12e-05	0.00161	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MCCC1—Parkinson's disease	5.03e-05	0.00158	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ND3—Parkinson's disease	5.03e-05	0.00158	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—ATP6AP2—Parkinson's disease	5e-05	0.00157	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	4.76e-05	0.0015	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—OMD—Parkinson's disease	4.73e-05	0.00148	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TALDO1—Parkinson's disease	4.73e-05	0.00148	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	4.72e-05	0.00148	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—COMT—Parkinson's disease	4.7e-05	0.00147	CbGpPWpGaD
Rivastigmine—BCHE—Neuronal System—MAOA—Parkinson's disease	4.66e-05	0.00146	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—DCTN1—Parkinson's disease	4.57e-05	0.00144	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MCCC1—Parkinson's disease	4.48e-05	0.00141	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ND3—Parkinson's disease	4.48e-05	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NDUFB11—Parkinson's disease	4.48e-05	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—RPL14—Parkinson's disease	4.48e-05	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—RPL23A—Parkinson's disease	4.48e-05	0.00141	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GCH1—Parkinson's disease	4.27e-05	0.00134	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—OMD—Parkinson's disease	4.22e-05	0.00132	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TALDO1—Parkinson's disease	4.22e-05	0.00132	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—RPS8—Parkinson's disease	4.18e-05	0.00131	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	4.14e-05	0.0013	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	4.08e-05	0.00128	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NDUFB11—Parkinson's disease	4e-05	0.00126	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—RPL23A—Parkinson's disease	3.99e-05	0.00125	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—RPL14—Parkinson's disease	3.99e-05	0.00125	CbGpPWpGaD
Rivastigmine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	3.89e-05	0.00122	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.85e-05	0.00121	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	3.84e-05	0.0012	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GCH1—Parkinson's disease	3.81e-05	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—DBH—Parkinson's disease	3.81e-05	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GBA—Parkinson's disease	3.81e-05	0.0012	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—FBP1—Parkinson's disease	3.81e-05	0.0012	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	3.78e-05	0.00119	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—RPS8—Parkinson's disease	3.73e-05	0.00117	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	3.69e-05	0.00116	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	3.44e-05	0.00108	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—CASP3—Parkinson's disease	3.41e-05	0.00107	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—DBH—Parkinson's disease	3.4e-05	0.00107	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GBA—Parkinson's disease	3.4e-05	0.00107	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—FBP1—Parkinson's disease	3.4e-05	0.00107	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	3.18e-05	0.000998	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	3.16e-05	0.000994	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	3.16e-05	0.000991	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	3.14e-05	0.000985	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK8—Parkinson's disease	3.14e-05	0.000985	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	3.12e-05	0.00098	CbGpPWpGaD
Rivastigmine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	2.91e-05	0.000913	CbGpPWpGaD
Rivastigmine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	2.87e-05	0.000901	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—DDC—Parkinson's disease	2.8e-05	0.000878	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	2.74e-05	0.000861	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	2.7e-05	0.000849	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTA4—Parkinson's disease	2.64e-05	0.000829	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.61e-05	0.000819	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	2.51e-05	0.000788	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—DDC—Parkinson's disease	2.49e-05	0.000783	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—IGF2—Parkinson's disease	2.49e-05	0.000782	CbGpPWpGaD
Rivastigmine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—Parkinson's disease	2.48e-05	0.000779	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	2.47e-05	0.000777	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—PLA2G6—Parkinson's disease	2.38e-05	0.000747	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTA4—Parkinson's disease	2.36e-05	0.00074	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MAOB—Parkinson's disease	2.35e-05	0.000739	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	2.33e-05	0.00073	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.24e-05	0.000703	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—IGF2—Parkinson's disease	2.22e-05	0.000698	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—PLA2G6—Parkinson's disease	2.12e-05	0.000666	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MAOB—Parkinson's disease	2.1e-05	0.000659	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	2.08e-05	0.000653	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	2.07e-05	0.00065	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	2.06e-05	0.000648	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ND3—Parkinson's disease	2.06e-05	0.000647	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	2.06e-05	0.000647	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	2.05e-05	0.000644	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	2.04e-05	0.000641	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2e-05	0.000627	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	1.94e-05	0.000609	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—OMD—Parkinson's disease	1.94e-05	0.000609	CbGpPWpGaD
Rivastigmine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	1.9e-05	0.000597	CbGpPWpGaD
Rivastigmine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	1.87e-05	0.000589	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	1.84e-05	0.000577	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GCH1—Parkinson's disease	1.75e-05	0.00055	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2D6—Parkinson's disease	1.75e-05	0.000549	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CTGF—Parkinson's disease	1.72e-05	0.000539	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism of proteins—INS—Parkinson's disease	1.65e-05	0.000519	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYP2E1—Parkinson's disease	1.6e-05	0.000502	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—NQO1—Parkinson's disease	1.58e-05	0.000497	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—FBP1—Parkinson's disease	1.56e-05	0.000491	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—DBH—Parkinson's disease	1.56e-05	0.000491	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GBA—Parkinson's disease	1.56e-05	0.000491	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2D6—Parkinson's disease	1.56e-05	0.00049	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—TH—Parkinson's disease	1.56e-05	0.00049	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CTGF—Parkinson's disease	1.53e-05	0.000481	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—CYCS—Parkinson's disease	1.5e-05	0.00047	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism of proteins—INS—Parkinson's disease	1.47e-05	0.000463	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYP2E1—Parkinson's disease	1.43e-05	0.000448	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—NQO1—Parkinson's disease	1.41e-05	0.000443	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—TH—Parkinson's disease	1.39e-05	0.000437	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ND3—Parkinson's disease	1.35e-05	0.000423	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	1.35e-05	0.000423	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—CYCS—Parkinson's disease	1.34e-05	0.000419	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—COMT—Parkinson's disease	1.33e-05	0.000416	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTP1—Parkinson's disease	1.32e-05	0.000414	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MAOA—Parkinson's disease	1.32e-05	0.000413	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—HMOX1—Parkinson's disease	1.3e-05	0.000409	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—OMD—Parkinson's disease	1.27e-05	0.000398	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	1.27e-05	0.000398	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—ABCB1—Parkinson's disease	1.25e-05	0.000392	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GSTM1—Parkinson's disease	1.21e-05	0.000381	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	1.2e-05	0.000377	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—COMT—Parkinson's disease	1.18e-05	0.000371	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTP1—Parkinson's disease	1.18e-05	0.00037	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MAOA—Parkinson's disease	1.17e-05	0.000369	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—GPX1—Parkinson's disease	1.16e-05	0.000365	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—HMOX1—Parkinson's disease	1.16e-05	0.000364	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—DDC—Parkinson's disease	1.15e-05	0.00036	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GCH1—Parkinson's disease	1.15e-05	0.00036	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—ABCB1—Parkinson's disease	1.11e-05	0.00035	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	1.08e-05	0.00034	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GSTM1—Parkinson's disease	1.08e-05	0.00034	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—MTHFR—Parkinson's disease	1.07e-05	0.000336	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—GPX1—Parkinson's disease	1.04e-05	0.000325	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—DBH—Parkinson's disease	1.02e-05	0.000321	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—FBP1—Parkinson's disease	1.02e-05	0.000321	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GBA—Parkinson's disease	1.02e-05	0.000321	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—APOE—Parkinson's disease	9.97e-06	0.000313	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	9.75e-06	0.000306	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MAOB—Parkinson's disease	9.65e-06	0.000303	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—MTHFR—Parkinson's disease	9.56e-06	0.0003	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—APOE—Parkinson's disease	8.9e-06	0.000279	CbGpPWpGaD
Rivastigmine—ACHE—Metabolism—INS—Parkinson's disease	8.52e-06	0.000268	CbGpPWpGaD
Rivastigmine—BCHE—Metabolism—INS—Parkinson's disease	7.6e-06	0.000239	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—DDC—Parkinson's disease	7.5e-06	0.000235	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	7.08e-06	0.000222	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CTGF—Parkinson's disease	7.04e-06	0.000221	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	6.56e-06	0.000206	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—NQO1—Parkinson's disease	6.49e-06	0.000204	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—TH—Parkinson's disease	6.39e-06	0.000201	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	6.37e-06	0.0002	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MAOB—Parkinson's disease	6.31e-06	0.000198	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—CYCS—Parkinson's disease	6.14e-06	0.000193	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—COMT—Parkinson's disease	5.44e-06	0.000171	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	5.41e-06	0.00017	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MAOA—Parkinson's disease	5.4e-06	0.00017	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	5.34e-06	0.000168	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	5.12e-06	0.000161	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	4.97e-06	0.000156	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—GPX1—Parkinson's disease	4.76e-06	0.00015	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	4.69e-06	0.000147	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CTGF—Parkinson's disease	4.6e-06	0.000145	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	4.39e-06	0.000138	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	4.29e-06	0.000135	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—NQO1—Parkinson's disease	4.24e-06	0.000133	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—TH—Parkinson's disease	4.18e-06	0.000131	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—APOE—Parkinson's disease	4.09e-06	0.000128	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—CYCS—Parkinson's disease	4.01e-06	0.000126	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—COMT—Parkinson's disease	3.55e-06	0.000112	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	3.54e-06	0.000111	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MAOA—Parkinson's disease	3.53e-06	0.000111	CbGpPWpGaD
Rivastigmine—CYP2D6—Metabolism—INS—Parkinson's disease	3.49e-06	0.00011	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	3.49e-06	0.00011	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	3.35e-06	0.000105	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	3.25e-06	0.000102	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—GPX1—Parkinson's disease	3.11e-06	9.78e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	2.87e-06	9.02e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—APOE—Parkinson's disease	2.67e-06	8.4e-05	CbGpPWpGaD
Rivastigmine—CYP3A4—Metabolism—INS—Parkinson's disease	2.28e-06	7.18e-05	CbGpPWpGaD
